Estimation of cancer cases and deaths attributable to infection in China

Cancer Causes and Control

Volumn 22, Issue 8, 2011, Pages 1153-1161

  Xiang, Wang ^a,b   Shi, Ju Fang ^a,c   Li, Ping ^a   Wang, Jian Bing ^a   Xu, Li Na ^a   Wei, Wen Qiang ^a   Zhao, Fang Hui ^a   Qiao, You Lin ^a   Boffetta, Paolo ^d,e  

^a CANCER HOSPITAL   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CANCER RESEARCH DIVISION   (Australia)

^d INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Attributable fraction; Cancer; China; Infection

Indexed keywords

ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CARCINOGENESIS; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HODGKIN DISEASE; HUMAN; INFECTION; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; NASOPHARYNX CANCER; NONHODGKIN LYMPHOMA; NUTRITIONAL ASSESSMENT; OCCUPATIONAL EXPOSURE; OROPHARYNX CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; SMOKING; STOMACH CANCER; SURVIVAL RATE; SYSTEMATIC REVIEW; VACCINATION;

CAUSE OF DEATH; CHINA; FEMALE; HUMANS; MALE; NEOPLASMS; PREVALENCE; RISK FACTORS; VIRUS DISEASES;

EID: 82955163279     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9791-y     Document Type: Article

References (42)

1. Bouvard V, Baan R, Straif K et al (2009) A review of human carcinogens-part B: biological agents. Lancet Oncol 10:321-322
2. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030-3044
3. Wang JB, Jiang Y, Wei WQ, Yang GH, Qiao YL, Boffetta P (2010) Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control 21:959-965
4. Liang H, Wang J, Xiao H et al (2010) Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Public Health 10:730
5. LEVIN ML (1953) The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 9:5315-5341
6. Chen Z (2008) The third national retrospective sampling death survey. Peking Union Medical University Press, Beijing
7. Chen WQ (2009) Estimation of cancer incidence and mortality in China in 2004-2005. Zhonghua Zhong Liu Za Zhi 31:664-668
8. Yuan JM, Yu MC, Xu WW, Cockburn M, Gao YT, Ross RK (1999) Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort. Cancer Epidemiol Biomarkers Prev 8:621-624 (Pubitemid 29337323)
9. Limburg P, Qiao Y, Mark S et al (2001) Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 93:226-233 (Pubitemid 32166494)
10. Kamangar F, Qiao YL, Blaser MJ et al (2007) Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 96:172-176 (Pubitemid 46094658)
11. Shin A, Park S, Shin HR et al (2011) Population attributable fraction of infection-related cancers in Korea. Ann Oncol (epub)
12. Wang KJ, Wang RT (2003) Meta-analysis on the epidemiology of Helicobacter pylori infection in China. Zhonghua Liu Xing Bing Xue Za Zhi 24:443-446
13. Herrero R, Castellsague X, Pawlita M et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95: 1772-1783 (Pubitemid 38008900)
14. International Agency for Research on Cancer (2007) IARC Monographs on the evaluation of carcinogenic risk to humans: human papillomaviruses. IARC, Lyon, France
15. Ferlay J, Shin HR, Bray F, Forman D, Parkin DM (2010) GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France
16. Zhou XY, Fang JQ (2002) The application of Gibbs sampling in meta-analysis for case-control studies of HBV, HCV and dual infection in primary hepatocelluar carcinoma. Zhongshan Yi Ke Da Xue Xue Bao 23:165-167
17. Dal ML, Franceschi S (2006) Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15:2078-2085 (Pubitemid 44877029)
18. Mueller N, Evans A, Harris NL et al (1989) Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320:689-695 (Pubitemid 19072487)
19. Carpenter LM, Newton R, Casabonne D et al (2008) Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer 122:1319-1323 (Pubitemid 351287232)
20. Xia GL, Liu CB, Cao HL, Bi SL, Zhan MY, Su CA (1996) Prevalence of hepatitis B and C virus infections in the general Chinese population. Results: from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun 5:62-73
21. Ji J, Wang H, Chen W et al (2009) Population-based seroprevalence of human papillomavirus in Chinese women. Book of the 25th international papillomavirus conference and clinic & educational workshop (Malmö, Sweden). International Papillomavirus Society, p 30:4
22. Deng H, Zeng Y, Zheng YM et al (2003) Studies on mass survey of 413, 164 persons for NPC. China Oncol 13:109-111
23. Chien YC, Chen JY, Liu MY et al (2001) Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345:1877-1882
24. Autier P, Boffetta P, Boniol M, Boyle P, Ferlay J, Aurengo A (2007) Attributable causes of cancer in France in the year 2000. IARC working group reports, vol 3. IARC Press, Lyon, France, pp 41-46
25. Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347-353
26. Pisani P, Parkin DM, Munoz N, Ferlay J (1997) Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6:387-400 (Pubitemid 27270542)
27. Zanetti AR, Van DP, Shouval D (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26:6266-6273
28. Li RC, Yang JY, Gong J et al (2004) Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi 25:385-387
29. Qiao YL, Franceschi S, Belinson JL et al (2007) HPV Prevalence in Chinese women: a population-based multiple center survey in Mainland China. Beijing, China: 24th international Papillomavirus conference and clinical workshop
30. Shi JF, Canfell K, Lew JB, Qiao YL (2011) The burden of cervical cancer in China: Synthesis of the evidence. Int J Cancer (in press)
31. Shi JF, Qiao YL, Smith JS et al (2008) Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine 26(Suppl 12):M53-M59
32. Canfell K, Shi JF, Lew JB et al (2011) Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. Vaccine 29:2487-2494
33. Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE (1989) Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 49:2506-2509 (Pubitemid 19125586)
34. Ross RK, Yuan JM, Yu MC et al (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339: 943-946
35. Sakuma K, Saitoh N, Kasai M et al (1988) Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology 8:1642-1646 (Pubitemid 19021901)
36. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP (1990) Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 150:1051-1054 (Pubitemid 20155330)
37. International Agency for Research on Cancer (1996) IARC monographs on the evaluation of carcinogenic risks to humans: human immunodeficiency viruses and human T-cell lymphotropic viruses. IARC Press, Lyon, France
38. Xu LQ, Yu SH, Jiang ZX, Xu SH, Meng N, Zhu YG (1994) First report on the nationwide survey of the distribution of parasites in China-sampling design and evaluation of its efficiency. Chin J Parasitol Parasitic Dis 7:249-254
39. Shin HR, Lee CU, Park HJ et al (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 25:933-940
40. Raza SA, Clifford GM, Franceschi S (2007) Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 96:1127-1134 (Pubitemid 46608308)
41. Li W, Thompson CH, Xin D et al (2003) Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol 163:2185-2189 (Pubitemid 37466463)
42. Li W, Tran N, Lee SC et al (2007) New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis. Pathology 39:217-222 (Pubitemid 46439647)